Ugandan Scientists made a scientific breakthrough with two (2) locally developed herbal drugs that successfully completed clinical trials and are now due NDA certification to hit the market.
A triumphant revelation was made on the 10th February 2025 at the Uganda Media Centre of the two locally made herbal drugs that successfully made it through clinical trials (Tazcov & Vidicine).
Accompanied by clinicians from Makerere University Lung Institute, the Minister for Science, Technology and Innovation, Office of the President Hon. Dr. Monica Musenero Masanza said the drugs were confirmed safe & effective.
“This milestone not only positions Uganda as a leader in herbal medicine research but also paves the way for further advancements in science and technology, offering hope for affordable and effective healthcare solutions.” — A local journal quoted.]
Pathogen Economy
What you need to know about Tazcov and Vidicine clinical Trial Findings
Innovations of the Month
Both Tazcov and Vidicine are geared at treating acute respiratory infections which scientists have proven prevalent in both the elderly and infants. These, when ignored, are feared to advance into pneumonia.
Tazcov (attached to Busitema University) and Vidicine (from Kazire) underwent a two-year scientific clinical trial that saw their approval by government.
This is the first time local herbs in Uganda are going through a scientific standardisation procedure of this kind.According to lead investigator Prof. Bruce Kirenga, the clinical trials are categorised in four (4) phases:
- Safety
- Side Effects
- Confirmation
- Post Market Surveillance
